As GSK prepares for a demerger that will create an independent consumer healthcare business, GSK Consumer Healthcare CEO Brian McNamara has been named CEO designate of the forthcoming company.
Biosimilar ustekinumab will provide a treatment of autoimmune and inflammatory diseases such as plaque psoriasis, Crohn's disease and ulcerative colitis.
Douglas Hoey is tasked with leading the international group focused on building international recognition of community pharmacy, simultaneous with his leadership of NCPA.